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Abstract: 
We have previously shown that AMP-activated protein kinase (AMPK) can 
induce the resumption of meiosis in mouse oocytes maintained in meiotic 
arrest in vitro. The present study was carried out to determine whether AMPK 
activation is involved in hormone-induced maturation. Follicle-stimulating 
hormone (FSH) and the EGF-like peptide, amphiregulin (AR), are potent 
inducers of maturation in cumulus cell-enclosed oocytes (CEO). Within 3 h of 
FSH treatment, phosphoacetyl CoA carboxylase (ACC) levels were increased 
in germinal vesicle (GV)-stage oocytes when compared to non-stimulated 
controls and remained elevated throughout 9 h of culture, indicating AMPK 
activation. A similar response to AR was observed after 6 h of culture. Using 
PT172 antibody (binds only to activated AMPK), Western analysis 
demonstrated active AMPK in both FSH- or AR-treated GV-stage oocytes 
within 6 h. The AMPK inhibitors, compound C and adenine 9-beta-D-
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arabinofuranoside (araA), blocked FSH- or AR-induced meiotic resumption 
and ACC phosphorylation, further supporting a causal role for AMPK in 
hormone-induced meiotic resumption. Immunocytochemistry using anti-
PT172-AMPK antibody showed an increased diffuse cytoplasmic staining and 
more intense punctate staining in the germinal vesicles of oocytes following 
treatment with the AMPK activator, 5-aminoimidazole-4-carboxamide-1-beta-
D-ribofuranoside (AICAR), or with FSH or AR, and this staining was eliminated 
by compound C or a blocking peptide for the anti-PT172 antibody. Staining of 
oocytes from hCG-stimulated mice with the anti-PT172 antibody also showed 
pronounced label in the germinal vesicles within 1-2 h. Further, in oocytes 
from all groups, active AMPK was always observed in association with the 
condensed chromosomes of maturing oocytes. Taken together, these results 
support a role for AMPK in FSH and AR-induced maturation in vitro and hCG-
induced maturation in vivo. 
INTRODUCTION 
In mammals, the preovulatory gonadotropin surge stimulates 
meiotic resumption in fully-grown meiotically competent oocytes in 
vivo. When released from their follicles prior to the gonadotropin surge 
and cultured under optimal conditions, these oocytes spontaneously 
resume maturation without hormone stimulation, suggesting an 
inhibitory environment provided by the follicular somatic compartment. 
Several candidate molecules produced by cumulus or granulosa cells 
have been proposed to play this inhibitory role. The purine metabolite, 
hypoxanthine (HX), is present in the follicular fluid at a concentration 
sufficient to maintain oocyte meiotic arrest in vitro (Eppig et al., 
1985). Another putative factor, termed oocyte meiosis inhibitor (OMI), 
may also contribute to oocyte meiotic arrest (Tsafriri and Pomerantz, 
1986), though the compound has not been biochemically 
characterized. Moreover, oocyte cyclic adenosine monophosphate is a 
critical negative regulator of meiotic resumption (Conti et al, 2002; 
Eppig et al, 2004). Agents that increase cAMP levels, cAMP analogs, or 
factors that prevent degradation of cAMP reversibly maintain oocyte 
meiotic arrest in vitro. Recent evidence suggests that the oocyte is the 
principal site of cAMP production that operates under the control of the 
somatic compartment (Mehlmann et al, 2004; Hinckley et al, 2005; 
Ledent et al, 2005). 
FSH promotes the maturation of cumulus cell-enclosed oocytes 
(CEO) under meiosis-arresting conditions and enhances the 
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preimplantation developmental competence of oocytes matured in 
vitro (De La Fuente et al., 1999; Downs et al., 1988). When oocyte-
cumulus cell complexes are stimulated with FSH, cumulus cells 
generate a gap junction-transmitted positive signal that acts on 
oocytes to induce meiotic resumption (Downs, 2001). It has also been 
reported that within ~0.5-2 h of FSH treatment, the cumulus cells are 
stimulated to produce a meiosis-inducing paracrine signal(s) that acts 
on the oocyte to induce meiotic maturation (Byskov et al., 1997), 
although the biochemical character of the signal(s) is unclear at 
present. 
In vivo, the physiological stimulus for oocyte meiotic resumption 
is the luteininizing hormone surge (Stapleton et al., 1996). Distribution 
of the LH receptor, a G-protein coupled receptor, is restricted to the 
mural granulosa cells (Peng et al., 1991). The interaction of LH and its 
receptor leads to factors released by mural granulosa cells, functioning 
in an autocrine and paracrine manner to transduce the LH effects 
within follicle. It has been demonstrated that in rodents members of 
the epidermal growth factor (EGF) family of ligands play a critical role 
in mediating LH-induced oocyte maturation (Ashkenazi et al., 2005; 
Park et al., 2004). LH stimulation induces the transient and sequential 
expression of the EGF family members amphiregulin (AR), epiregulin 
and beta-cellulin (Park et al., 2004). Oocytes meiotically arrested in 
vitro can be induced to resume meiosis by treatment with EGF-like 
peptides in a cumulus cell-dependent manner (Ashkenazi et al., 2005; 
Downs and Chen, 2007; Park et al., 2004). Mice lacking AR showed 
delayed hCG-induced maturation and reduced cumulus expansion 
(Hsieh et al., 2007), indicating the physiological role of AR in 
regulation of meiotic induction. 
By regulating the degradation of cAMP, phosphodiesterase (PDE) 
plays an essential role in oocyte meiotic resumption. In rodents, 
oocyte cAMP hydrolysis is thought to be primarily accomplished by 
PDE3A (Richard et al., 2001; Shitsukawa et al., 2001). Oocytes lacking 
PDE3A contained increased cAMP levels and failed to undergo 
spontaneous maturation in vitro (Masciarelli et al., 2004). During 
oocyte maturation in vitro or in vivo, an increase of PDE activity is 
observed (Han et al., 2006; Richard et al., 2001; Tsafriri et al., 1996) 
and mediates a decrease in oocyte cAMP that precedes meiotic 
resumption. 
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The activity of AMP-activated protein kinase (AMPK), a cellular 
energy sensor, is sensitively regulated by AMP, a byproduct of cAMP 
degradation. This protein Ser/Thr kinase, comprised of a catalytic α 
subunit and regulatory β and γ subunits, was initially discovered as an 
inhibitor of acetyl CoA carboxylase and 3-hydroxy-3-methyglutaryl-
CoA reductase (Carling et al., 1987). An upstream kinase (AMPKK) 
activates AMPK through specific phosphorylation on the threonine-172 
(Thr172) residue of the α subunit (Hawley et al., 1996). In a previous 
study, we have shown that activation of AMPK provides a positive 
stimulus for mouse oocyte meiotic resumption in vitro (Chen et al., 
2006; Downs et al., 2002). Although evidence indicates that an 
increase in oocyte AMPK activity can trigger GVB, the physiological 
significance of this relationship is not known. 
In this study, we show by Western analysis and 
immunofluorescent staining that AMPK activity is increased in FSH- or 
AR-stimulated oocytes before GVB and that hormone-induced 
maturation is blocked by inhibitors of AMPK activation. AMPK is also 
activated within-GV-stage oocytes of hCG-treated mice. These results 
provide compelling evidence for AMPK mediation of hormone-
stimulated GVB in mouse oocytes. 
MATERIALS AND METHODS 
Oocyte isolation and culture conditions 
C57BL/6JxSJL/J Fl mice, 19–23 days old, were used for all 
experiments. Mice were primed with 5 IU equine choronic 
gonadotropin and killed 48 h later by cervical dislocation. Ovaries were 
removed and placed in the culture medium, and cumulus cell-enclosed 
oocytes (CEO) were obtained by puncturing large antral follicles with 
sterile needles. Oocytes were cultured in Eagle’s minimum essential 
medium with Earle’s salts (GIBCO), supplemented with 0.23 mM 
pyruvate, penicillin, streptomycin sulfate and 3 mg/ml crystallized 
lyophilized bovine serum albumin (ICN ImmunoBiologicals, Lisle, IL) 
and buffered with 26 mM bicarbonate. Tubes were gassed with a 
humidified mixture of 5% CO2, 5% O2 and 90% N2 and placed in a 
water bath at 37°C for the duration of culture. 
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Western Analysis 
After different treatments, oocytes were denuded by repeated 
pipetting through mouth-operated small bore pipettes in cold culture 
medium and washed in phosphate-buffered saline (PBS, pH 7.4)/PVP 
(3 mg/ml) plus protease inhibitors (Protease Inhibitors Cocktail 
Tablets, 1 mM Na orthovanadate, 2 μg/ml pepstatin, 50 mM beta-
Glycerophospate) and then added to an equal volume of 2× Laemmli’s 
buffer containing 20% beta-mercaptoethanol. After heating at 95°C for 
5 min, samples were stored frozen at −80°C until used for Western 
blotting. To detect phospho-ACC levels, proteins were electrophoresed 
on a 3–8% Tris-Acetate mini Gel (Invitrogen) for 1 h at 150 V and 
then transferred to nitrocellulose at 100 V for 1 h. For active AMPK 
(PT172) blots (figure 1B, C), samples were electrophoresed on a 4–
12% Bis-Tris SDS mini Gel (Invitrogen) for 50 min at 100 V and then 
in a semi-dry system transferred to nitrocellulose at 250 mA for 2 h at 
4°C. After blocking with 5% nonfat milk for 2 h at room temperature, 
blots were then incubated with primary antibodies (anti-PT172 or anti-
phospho-ACC, 1:250) overnight at 4°C, washed in Tris-buffered saline 
(TBS pH 7.4) and incubated with HRP-conjugated goat-anti-rabbit IgG 
(1:1000, in 5% nonfat milk) for 1 h at room temperature. After 
washing in TBS, detection was performed with Supersignal Western 
Dura Chemiluminescent Substrate (Pierce) and exposed to film. Blots 
were stripped and reprobed with ACC antiserum (1:2000) as a loading 
control. 
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Figure 1 AMPK activation in FSH-or AR-treated GV-stage oocytes. (A) Western 
analysis of phospho-ACC in FSH-stimulated oocytes. CEO were denuded and extracted 
after culture with or without FSH in dbcAMP-supplemented medium for the indicated 
times. All oocytes were at the GV-stage, except a group of GVB-stage oocytes were 
collected after 9 h FSH treatment. Western analysis of PT172-AMPK in GV-stage 
oocytes after 6 h culture in the absence (Con) or presence of 0.1 μl/ml FSH (B) or 50 
ng/ml AR (C) in dbcAMP-containing medium. 
Immunofluorescent staining 
After different treatments, CEO were denuded and fixed with 
4% paraformadehyde for 1 h at 4° C, and then permeablized with 
0.1% Triton in blocking buffer (0.05% saponin in PBS, PH 7.4, plus 
10% sheep serum) for 30 min. Oocytes were then washed free of 
Triton and continuously blocked for another 90 min at room 
temperature. Oocytes were incubated with primary antibodies (1:100) 
overnight at 4° C and then washed in wash buffer (PBS containing 
1mg/ml BSA and 0.05% saponin) and incubated with FITC-conjugated 
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sheep-anti-rabbit antibody (1:1000) at room temperature for 1 h. 
After washing, propidium iodine (PI, 20 μg/ml) was applied to 
counterstain the chromosomes. Images were observed with a confocal 
microscope. 
Confocal Microscopy 
Oocytes were viewed on a laser scanning confocal microscope 
(Carl Ziess Co.) with a 40× objective. During imaging all settings were 
kept constant, i.e. laser power, detector gain, amplifier offset, 
amplifier gain and pinhole size. Digitally recorded images were 
exported by LSM Examiner (Carl Ziess Co.). 
Chemicals 
Saponin, propidium iodide, araA, dbcAMP, sheep serum, and 
FITC-labeled sheep-anti-rabbit antibody were purchased from Sigma 
Chemical Co. (St. Louis, MO). Compound C and AICAR were supplied 
by Toronto research Chemicals, Inc. (North York, Ontario). Anti-pACC 
antibody was purchased from Upstate Biotechnology Inc. (Lake Placid, 
NY), anti-ACC antibodies were provided by Dr. Grahame Hardie, anti- 
PT172 antibody was from Cell Signaling Technology (Beverly, MA), and 
anti-PT172-specific blocking peptide came from Santa Cruz Biotech. 
Inc. (Santa Cruz, CA). HRP-conjugated goat-anti-rabbit antibody and 
Supersignal western dura chemiluminescent substrate were obtained 
from Pierce (Rockford, IL) and vectashield mounting medium from 
Vector Laboratories, Inc. (Burlingame, CA). Highly purified ovine FSH 
was obtained from the National Hormone and peptide Program (NHPP), 
NIDDK, and Dr. A.F. Parlow. 
Statistical Analysis 
Oocyte maturation experiments were repeated at least 3 times 
with at least 30 oocytes per group per experiment. Data are reported 
as mean percentage GVB ± SEM. Following arcsin transformation, 
maturation frequencies were analyzed statistically by ANOVA followed 
by Duncan’s multiple range test. For all statistical analyses, a P value 
less than 0.05 was considered significant. 
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RESULTS 
AMPK activity is increased in FSH-treated oocytes 
before GVB 
dbcAMP-arrested oocytes treated with FSH initiate meiosis 
between 4 and 6 h of culture and about 60% are induced to resume 
maturation after 10 h (Downs and Chen, 2007). If AMPK is involved in 
FSH-induced maturation, it should be activated before meiotic 
resumption. Acetyl-CoA carboxylase (ACC), a key enzyme involved in 
fatty acid metabolism, is an important substrate of active AMPK 
(Davies et al., 1992). To assess AMPK activity in FSH-treated GV-stage 
oocytes, a time course of phospho-ACC levels was determined by 
Western analysis. CEO were cultured in 300 μM dbcAMP with or 
without FSH for 3, 6 or 9 h. After culture, cumulus cells were removed 
and GV-stage denuded oocytes from all culture groups or GVB-stage 
oocytes from the 9 h treatment group were collected and analyzed by 
Western analysis. At all time points, GV-stage oocytes treated with 
FSH contained increased phospho-ACC levels compared to the control 
groups (figure 1A), indicating that FSH stimulated AMPK activation in 
oocyte before meiotic resumption. Interestingly, the amount of 
phospho-ACC decreased to the basal level in oocytes that resumed 
meiosis after 9 h of FSH stimulation. 
To confirm AMPK activation and directly detect active AMPK, 
Western analysis using anti-PT172 antibody was performed. Cellular 
extracts were collected from GV-stage oocytes cultured for 6 h with or 
without FSH in dbcAMP-containing medium. Consistent with phospho-
ACC levels, PT172-AMPK levels were increased in FSH-stimulated GV-
stage oocytes, indicating FSH treatment activates intra-oocyte AMPK 
before oocyte maturation (figure 1B). 
AMPK inhibitors block AMPK activation and FSH-induced 
maturation 
Compound C, a small molecule AMPK inhibitor (Zhou et al., 
2001), blocks AICAR-induced maturation by decreasing AMPK activity 
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in oocytes (Chen et al., 2006). To test whether AMPK activation 
mediates FSH-induced maturation, CEO were preincubated increasing 
concentrations of compound C for 0.5 h in 300 μM dbcAMP before 
addition of 0.1 μg/ml FSH. After 17–18 h of culture, GVB percentage 
was assessed. FSH increased the maturation percentage from 10% to 
70%, and this stimulation was eliminated in a dose-dependent manner 
by compound C (figure 2A). 
 
Figure 2 Effects of compound C and araA on FSH-induced maturation and ACC 
phosphorylation. CEO were precultured for 0.5 h with increasing doses of compound C 
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(A) or araA (B) in 300 μM dbcAMP. FSH (0.1 μg/ml) was then added and cultures were 
continued for 17–18 h before assessment of GVB percentage. Groups with no common 
letters are significantly different. (C) Western analysis of phospho-ACC in compound C 
or araA-treated GV-stage oocytes. CEO were preincubated 0.5 h with 5 μM compound 
C or 1 mM araA in 300 μM dbcAMP before addition of FSH. After 6 h of culture, GV-
stage oocytes were prepared for the Western analysis. 
araA is the precursor of araATP, which is a competitive inhibitor 
of AMPK (Henin et al., 1996), and its effects on FSH-induced 
maturation were also determined. CEO were maintained in meiotic 
arrest with 300 μM dbcAMP and pretreated with increasing 
concentrations of araA for 0.5 h before addition of 0.1 μg/ml FSH. 
Maturation percentages were determined after 17–18 h of culture. 
araA dose-dependently blocked FSH-induced maturation, with a 
complete suppression at 1 mM (figure 2B). These data further support 
the idea that AMPK activation mediates FSH-induced maturation. 
To assess the effect of compound C or araA on AMPK activity in 
these oocytes, phospho-ACC levels were determined in GV-stage 
oocytes by Western analysis. CEO were cultured in 300 μM dbcAMP 
and pretreated with 5 μM compound C or 1 mM araA for 0.5 h before 
addition of FSH. After 6 h of culture, cumulus cells were removed and 
denuded GV-stage oocytes were processed for Western analysis. 
Figure 2C shows that FSH treatment increased phospho-ACC levels 
compared to oocytes cultured in dbcAMP alone, and exposure of FSH-
treated oocytes to either compound C or araA eliminated the increase 
in ACC phosphorylation, indicating suppression of AMPK activity within 
oocytes. 
AMPK activation mediates Amphiregulin-induced 
maturation 
Amphiregulin (AR), an EGF-like peptide, mediates LH-stimulated 
maturation in vivo (Hsieh et al., 2007) and induces CEO meiotic 
resumption in vitro (Downs and Chen, 2007; Park et al., 2004). To test 
whether AMPK activation is involved in AR-induced maturation, after 6 
h treatment in the absence or presence of AR, CEO were denuded and 
extracts from 500 GV-stage oocytes were subjected to Western 
analysis. As shown in figure 1C, active AMPK and phospho-ACC levels 
were elevated in AR-treated oocytes before meiotic maturation. 
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The AMPK inhibitors, compound C and araA, were tested on AR-
induced maturation to assess the involvement of AMPK. CEO were 
pretreated with increasing concentrations of compound C or araA in 
dbcAMP-containing medium for 0.5 h before addition of 50 ng/ml AR, 
and cultures were continued for 17–18 h before assessment of GVB. 
AR increased the maturation percentage in CEO from 10% to 81%, 
which was dose-dependently blocked by compound C (figure 3A) or 
araA (figure 3B). Western analysis showed that the AR-stimulated 
phosphorylation of ACC was suppressed by compound C or araA 
(figure 3C), demonstrating inactivation of AMPK. 
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Figure 3 Effects of compound C and araA on AR-induced maturation and ACC 
phosphorylation. CEO were pretreated with increasing concentrations of compound C 
(A) or araA (B) in 300 μM dbcAMP for 0.5 h. AR (50ng/ml) was then added and 
cultures were continued for 17–18 h before assessment of GVB. Groups with no 
common letters are significantly different. (C) Western analysis of phospho-ACC in 
compound C or araA-treated oocytes. CEO were preincubated 0.5 h with 5 μM 
compound C or 2 mM araA in 300 μM dbcAMP before addition of AR. CEO were 
denuded after 6 h of culture and GV-stage oocytes were collected and processed for 
Western analysis. 
Immunofluorescent localization of active AMPK (PT172-
AMPK) 
AICAR stimulation Immunofluorescent staining using anti-PT172 
antiserum was performed to directly observe active AMPK in the 
oocytes following treatment with the AMPK activator, AICAR. After 6 h 
of culture in medium containing dbcAMP with or without 1 mM AICAR, 
oocytes were denuded, fixed with 4% paraformaldehyde and stained 
for immunofluorescence using anti-PT172 antiserum. Counterstaining 
with propidium iodide (PI) enabled an assessment of AMPK localization 
in relation to the germinal vesicle in immature oocytes or condensed 
chromosomes following meiotic resumption. Control groups for 
nonspecific staining were carried out in which either primary antibody 
was omitted or a blocking peptide representing the phosphorylated 
peptide recognition site was added to neutralize the primary antibody. 
In the control group, in which primary antibody was omitted, a very 
faint fluorescence was uniformly distributed throughout the oocyte 
(data not shown). Fluorescence was never seen in the nucleolus in any 
of the groups. Oocytes meiotically arrested in dbcAMP-supplemented 
medium contained a diffuse fluorescence throughout the cell, which 
was above the background (figure 4A). AICAR stimulation resulted in a 
stronger diffuse signal in the cytoplasm, but most notable was an 
intense punctate labeling in the germinal vesicle (figure 4B). In all 
GVB-stage oocytes, even those spontaneously maturing in dbcAMP 
alone, a punctate staining pattern was observed associated with the 
condensed chromosomes (figure 4C). Pretreatment of oocytes with 
compound C (figure 4D) or pretreatment of antibody with a blocking 
peptide containing the specific peptide sequence recognized by the 
antibody (figure 4E) eliminated both the increased cytoplasmic 
staining as well as the punctate nuclear staining. When quantified, 
75% of AICAR-treated GV-stage oocytes exhibited nuclear staining, 
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compared to 11% of controls, and compound C completely prevented 
the AICAR-stimulated response (figure 5). 
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Figure 4 Localization of active AMPK in AICAR-stimulated CEO. After 6 h of culture, 
cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172 
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP 
alone (control), GV-stage; (B) AICAR, GV-stage; (C) AICAR, GVB-stage; (D) AICAR, 
GV-stage; primary antibody was neutralized with a specific blocking peptide; (E) 
AICAR plus compound C, GV-stage; CEO were preincubated with 5 μM compound C in 
300 μM dbcAMP before the addition of 1 mM AICAR. Oocytes were stained with 
propidium iodide (PI) for detection of chromatin. The bar represents 50 μm. 
 
 
Figure 5 Effect of compound C on the percentage of GV-stage oocytes that 
contained nuclear PT172 staining after 6 h of culture in 1 mM AICAR. 
FSH stimulation  To test if FSH-treated oocytes exhibited a similar 
staining pattern, immunocytochemistry was performed on dbcAMP-
arrested CEO stimulated with FSH for 6 h. Similar to AICAR-stimulated 
CEO, GV-stage oocytes treated with FSH exhibited increased diffuse 
staining in the cytoplasm and intense punctate fluorescence in the 
nucleus (figure 6B) compared to a faint diffuse staining pattern in 
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untreated controls (figure 6A). When oocytes resumed meiosis, active 
AMPK was again consistently observed in association with the 
condensed chromosomes. Compound C, at a concentration that 
eliminated FSH-induced maturation, also prevented the punctate 
nuclear staining and reduced the diffuse cytoplasmic staining (figure 
6D, ,77). 
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Figure 6 Localization of active AMPK in FSH-stimulated CEO. After 6 h of culture, 
cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172 
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP 
alone (control), GV-stage; (B) FSH (0.1μg/ml), GV-stage; (C) FSH (0.1μg/ml), GVB-
stage; (D) FSH (0.5 μg/ml) plus compound C, GV-stage; CEO were preincubated with 
5 μM compound C in 300 μM dbcAMP before the addition of FSH. Oocytes were stained 
with propidium iodide (PI) for detection of chromatin. The bar represents 50 μm. 
 
Figure 7 Effect of compound C on the percentage of GV-stage oocytes that 
contained nuclear PT172-AMPK staining after 6 h of culture in FSH. 
Amphiregulin stimulation  Experiments were next performed to 
determine the active AMPK staining pattern in AR-treated oocytes. 
dbcAMP-arrested CEO treated 6 h with AR exhibited the same pattern 
of staining, with an increase in diffuse cytoplasmic staining and 
pronounced punctate staining in the germinal vesicle of immature 
oocytes (figure 8B) and around the condensed chromosomes of 
oocytes that had resumed maturation (figure 8C). Compound C again 
prevented this increased staining (figure 8D). 
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Figure 8 Localization of active AMPK in AR-stimulated CEO. After 6 h of culture, 
cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172 
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP 
alone (control), GV-stage; (B) AR, GV-stage; (C) AR, GVB-stage; (D) AR plus 
compound C, GV-stage; CEO were preincubated with 5 μM compound C in 300 μM 
dbcAMP before the addition of AR. Oocytes were stained with propidium iodide (PI) for 
detection of chromatin. The bar represents 50 μm. 
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When a dose response experiment was carried out with AR 
using concentrations of 2.5, 10, and 50 ng/ml, a dose-dependent 
stimulation of meiotic resumption in dbcAMP-arrested oocytes was 
observed that was paralleled by corresponding increases in the 
frequency of nuclear staining in GV-stage oocytes using anti-PT172 
antibody (figure 9A). Thus, as the maturation-inducing potency of AR 
was increased, so was its ability to stimulate AMPK activation within 
the GV of immature oocytes. Compound C abolished the increased 
nuclear staining brought about by 50 ng/ml AR (figure 9B). 
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Figure 9 Effects of AR and compound C on nuclear PT172-AMPK staining. (A) 
Effect of AR dose on oocyte maturation and nuclear staining. CEO were cultured 6 h in 
medium containing 300 μM dbcAMP plus increasing dose of AR and the frequencies of 
both GVB and nuclear staining in GV-stage oocytes were determined. (B) Inhibitory 
effect of compound C on the percentage of GV-stage oocytes that contained nuclear 
PT172-AMPK staining after 6 h of culture in AR. 
hCG stimulation in vivo  To determine if AMPK activation within the 
oocytes occurs prior to meiotic resumption in vivo, eCG-primed mice 
were treated with 5 IU hCG and oocyte-cumulus cell complexes were 
isolated at 1, 2 and 3.5 h post-hCG and processed for 
immunofluorescence using anti-PT172 antibody. A separate set of 
primed mice was injected with the PBS vehicle as controls. As shown 
in figure 10, very little label was detected in the 0 h group, but as 
early as 1 h after hCG injection a slight increase in staining intensity 
was evident in the germinal vesicle that became very pronounced after 
2 h. In two experiments, 41 out of a total of 74 oocytes (55.4 %) 
isolated 2 h post-hCG displayed this increased nuclear staining. As 
with oocytes stimulated in vitro, blocking peptide eliminated the 
increase in nuclear fluorescence (data not shown), confirming the 
specificity for active AMPK in vivo. Such staining was not observed in 
oocytes from vehicle-treated mice at any time point. Nearly all of the 
oocytes (90%) isolated 3.5 h post-hCG had undergone GVB and, of 
these, 100% showed intense phospho-PT172 staining that colocalized 
with the condensed chromosomes (figure 10). Although an increase in 
diffuse cytoplasmic fluorescence was apparent in oocytes that had 
resumed maturation, this increase was more subtle in immature 
oocytes from hCG-stimulated animals. Interestingly, a common finding 
in oocytes from hCG-treated mice were foci of intense staining in the 
cytoplasm and sometimes in the germinal vesicle that were usually 
larger than the aggregations of label in oocytes receiving an inducing 
signal in vitro. 
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Figure 10 Localization of active AMPK in oocytes from hCG-stimualted mice. eCG-
primed mice were injected with 5 IU hCG and 0, 1, 2 or 3.5 h later oocytes were 
isolated, fixed and stained with rabbit anti-PT172 AMPK antiserum followed by FITC-
labeled sheep anti-rabbit antiserum. Oocytes were stained with propidium iodide (PI) 
for detection of chromatin. Note that two cumulus cell nuclei stain intensely with 
propidium iodide on the bottom portion of the micrograph of the 1 h group. The bar 
represents 50 μm. 
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DISCUSSION 
In this study, we have demonstrated the participation of AMPK 
in hormone-induced maturation of mouse CEO in vitro. FSH triggered 
AMPK activation in oocytes before meiotic resumption, and the AMPK 
inhibitors, compound C and araA, blocked both FSH-induced 
maturation and the FSH-stimulated increase in AMPK activity in GV-
stage oocytes. Identical results were observed in AR-stimulated 
oocytes. By immunofluorescence microscopy using anti-PT172 
antibody, increased diffuse cytoplasmic staining and punctate staining 
in the germinal vesicle were observed in oocytes stimulated with FSH 
or AR, similar to the staining pattern in AICAR-stimulated oocytes. 
With each stimulatory protocol, the increase in active AMPK staining 
was eliminated by compound C. AMPK was also shown to be activated 
prior to meiotic resumption in oocytes from hCG-stimulated mice. 
These results demonstrate the essential involvement of AMPK in 
hormone-induced maturation. 
FSH is an effective inducer of meiotic resumption in arrested 
mouse CEO in vitro. FSH binding to its receptor on the cumulus cells 
activates a cAMP–regulated pathway (Tayar, 1996) and generates a 
positive stimulus to induce maturation in a gap junction-dependent 
manner (Downs, 2001; Downs et al., 1988). The nature of this positive 
stimulus and the means by which it brings about GVB remain active 
areas of research. We show that FSH stimulation for 3 h is sufficient to 
increase ACC phosphorylation in GV-stage mouse oocytes, indicating 
AMPK activation. In addition, immunoblotting and immunofluorescent 
staining using anti-PT172 antiserum directly showed an increase of 
active AMPK in FSH-treated GV-stage oocytes. These observations are 
consistent with AMPK involvement in FSH-induced meiotic resumption, 
since the kinase is activated prior to meiotic resumption. Support for 
this idea was provided by the use of the AMPK inhibitors, compound C 
(Zhou et al., 2001) and araA (precursor of araATP, (Henin et al., 
1996)), which blocked both hormone-induced maturation and AMPK 
activation. 
In a normal reproductive cycle, it is the LH surge that regulates 
oocyte maturation in vivo. It has been shown that EGF-like peptides, 
such as amphiregulin (AR), epiregulin, and betacellulin, mediate LH-
induced effects on oocyte meiotic maturation in rodents (Ashkenazi et 
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al., 2005; Hsieh et al., 2007; Park et al., 2004). A model system has 
been proposed in which secretion of EGF-like peptides by the mural 
granulosa cells in response to gonadotropin stimulation functions in an 
autocrine and paracrine manner to transduce the hormone effects in 
the follicle (Park et al., 2004). In cultured CEO, FSH induces AR mRNA 
expression within 0.5 h by a prostaglandin synthase 2 and 
progesterone receptor-dependent mechanism (Shimada et al., 2006). 
In addition, a recent study showed that AR mediates FSH-induced 
maturation in mouse oocytes in vitro (Downs and Chen, 2007). 
Therefore, it was important to test whether AMPK is involved in oocyte 
maturation mediated by EGF-like peptides. Indeed, Western analysis 
indicated that AR induces AMPK activation in mouse oocytes before 
GVB, and this was confirmed by immunocytochemistry. Moreover, as 
in FSH-treated CEO, AR-induced oocyte maturation and AMPK 
activation were blocked by AMPK inhibitors, further supporting the 
involvement of AMPK in AR-induced maturation. 
By immunofluorescent staining, we showed that a considerable 
portion of active AMPK α subunit accumulated in the germinal vesicle 
after AICAR, FSH or AR stimulation in vitro or hCG stimulation in vivo. 
Evidence for the active AMPK specificity of this staining stems from its 
elimination by treatment of oocytes with compound C or treatment of 
antibody with a specific blocking peptide. In Drosophila melanogaster, 
the AMPK homologue, DmAMPK, has also been shown to be associated 
with the nucleus when it was activated by oligomycin (Pan and Hardie, 
2002). Moreover, in yeast, the AMPK homologue, SNF1, translocalizes 
from cytoplasm to the nucleus in response to alkaline pH but not 
sodium ion stress (Hong and Carlson, 2007). It is tempting to 
speculate that active AMPK within the germinal vesicle is important for 
its meiosis-inducing action. However, it should be noted that an 
increased diffuse cytoplasmic staining was also observed in stimulated 
CEO, through it was of lesser intensity. 
In mammals, the AMPK catalytic subunit contains two isoforms, 
α1 and α2, which are encoded by different genes. In somatic cells, α1-
AMPK is only present in the cytoplasm, whereas α2 is mainly localized 
in the nucleus (Salt et al., 1998; Stapleton et al., 1996; Turnley et al., 
1999). A recent study showed that in a mouse myoblast cell line, α2 
and α1 isoforms are both localized in the cytoplasm, while activation of 
AMPK results in α2, but not α1, translocation into the nucleus (Suzuki 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Developmental Biology, Vol. 313, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
23 
 
et al., 2007). Interestingly, we have observed increased α1 AMPK 
accumulation in or around the germinal vesicle of AICAR-stimulated 
oocytes (unpublished data), suggesting a movement of this subunit 
from the cytoplasm into the GV prior to meiotic resumption. Thus, 
different active AMPK isoform dynamics may be manifest in mouse 
oocytes when compared to somatic cells, but clarification awaits 
further study. 
Immunofluorescent staining of oocytes from hCG-stimulated 
animals also revealed that AMPK was activated prior to GVB in vivo. An 
increase in fluorescence was observed 1 h after hCG injection that 
became significantly more intense by 2 h post-hCG. Moreover, as was 
observed in oocytes stimulated in vitro by AICAR, FSH or AR, active 
AMPK was always observed in association with the condensed 
chromosomes of maturing oocytes. Taken together, our data support a 
physiological role for AMPK in hormone-induced maturation both in 
vitro and in vivo. However, an interesting difference in staining pattern 
was observed in that oocytes in vitro tended to have smaller, punctate 
staining, while those maturing in vivo had fewer, but larger, 
concretions of fluorescence. The significance of these differences is not 
known and they provide a challenge for future experimentation. 
The observation that active AMPK accumulated around the 
periphery of condensed chromosomes in all maturing oocytes suggests 
that AMPK participates in subsequent events leading to the completion 
of meiosis I, such as the segregation of chromosomes. Indeed, we 
have reported increased frequencies of metaphase II oocytes following 
in vitro culture in the presence of AICAR (Downs and Chen, 2006). A 
study in Saccharomyces cerevisiae has shown that the AMPK 
homologue, SNF1, is required for both early (DNA replication and 
meiotic recombination) and late (meiotic chromosome segregation and 
spore formation) stages of meiosis through different mechanisms 
(Honigberg and Lee, 1998). It will be interesting to determine the 
pattern of AMPK activation throughout maturation and fertilization in 
the mouse and its involvement in these later developmental stages. 
Data presented herein and in previous studies have 
demonstrated a meiosis-inducing action of AMPK in mouse oocytes. 
The present study is important because it implicates AMPK in 
hormone-induced oocyte maturation in the mouse, thereby verifying a 
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physiological role in meiotic regulation. Curiously, in oocytes from two 
other species, cow and pig, AMPK has the opposite action on oocyte 
maturation (Bilodeau-Goeseels et al., 2007; Mayes et al., 2007; Tosca 
et al., 2007). In a recent study, Mayes et al. (2007) showed that 
activation of AMPK transiently suppressed the spontaneous maturation 
of pig oocytes, and that this effect was mediated by the cumulus cells. 
A similar cumulus cell-dependent inhibitory effect was reported by 
Tosca et al (2007) when bovine oocytes were treated with the AMPK 
activator, metformin. Bilodeau-Goeseels et al (2007) also reported 
suppression of bovine maturation with AICAR and metformin, but 
these agents were effective in both CEO and DO. These findings are 
striking not only because the response to AMPK activation is one of 
meiotic suppression, but also because the site of action may vary 
between germ and somatic compartments. Thus, fundamental 
differences exist in meiotic regulation of mammalian oocytes that 
serve to emphasize the difficulty in extrapolating experimental findings 
to another species. As a further example of this, in preliminary 
experiments we have been unable to stimulate GVB in rat oocytes with 
AICAR or a brief heat shock, both of which are effective meiotic 
inducers in mice (Downs et al., 2002; LaRosa and Downs, 2007). It is 
apparent that the mouse possesses unique physiological characteristics 
associated with the control of meiotic resumption. A future challenge 
will be the delineation of similarities as well as differences between 
mammalian species in how oocyte maturation is regulated. 
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